| Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and … SC Palmer, A Hayen, P Macaskill, F Pellegrini, JC Craig, GJ Elder, ... Jama 305 (11), 1119-1127, 2011 | 942 | 2011 |
| Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies S Palmer, M Vecchio, JC Craig, M Tonelli, DW Johnson, A Nicolucci, ... Kidney international 84 (1), 179-191, 2013 | 905 | 2013 |
| Associations between hemodialysis access type and clinical outcomes: a systematic review P Ravani, SC Palmer, MJ Oliver, RR Quinn, JM MacRae, DJ Tai, ... Journal of the American Society of Nephrology 24 (3), 465-473, 2013 | 810 | 2013 |
| KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease IH de Boer, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ... Kidney international 98 (4), S1-S115, 2020 | 568 | 2020 |
| Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials G De Berardis, M Sacco, GFM Strippoli, F Pellegrini, G Graziano, ... Bmj 339, 2009 | 552 | 2009 |
| Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials GFM Strippoli, SD Navaneethan, DW Johnson, V Perkovic, F Pellegrini, ... Bmj 336 (7645), 645-651, 2008 | 546 | 2008 |
| Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review M Franciosi, G Lucisano, E Lapice, GFM Strippoli, F Pellegrini, A Nicolucci PloS one 8 (8), e71583, 2013 | 520 | 2013 |
| HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. SD Navaneethan, F Pansini, V Perkovic, C Manno, F Pellegrini, ... The Cochrane database of systematic reviews, CD007784-CD007784, 2009 | 510* | 2009 |
| Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta … SC Palmer, B Tendal, RA Mustafa, PO Vandvik, S Li, Q Hao, D Tunnicliffe, ... Bmj 372, 2021 | 502 | 2021 |
| Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review GFM Strippoli, M Craig, JJ Deeks, FP Schena, JC Craig Bmj 329 (7470), 828, 2004 | 498 | 2004 |
| Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis SC Palmer, D Mavridis, A Nicolucci, DW Johnson, M Tonelli, JC Craig, ... Jama 316 (3), 313-324, 2016 | 481 | 2016 |
| Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials EM Hodson, CA Jones, AC Webster, GFM Strippoli, PG Barclay, K Kable, ... The Lancet 365 (9477), 2105-2115, 2005 | 468 | 2005 |
| Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis SC Palmer, D Mavridis, E Navarese, JC Craig, M Tonelli, G Salanti, ... The Lancet 385 (9982), 2047-2056, 2015 | 466 | 2015 |
| Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease SC Palmer, SD Navaneethan, JC Craig, DW Johnson, M Tonelli, AX Garg, ... Annals of internal medicine 153 (1), 23-33, 2010 | 463 | 2010 |
| Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy C Manno, GFM Strippoli, L Arnesano, C Bonifati, N Campobasso, ... Kidney international 66 (4), 1570-1577, 2004 | 431 | 2004 |
| Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients EM Hodson, M Ladhani, AC Webster, GFM Strippoli, JC Craig Cochrane database of systematic reviews, 2013 | 429 | 2013 |
| Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis SC Palmer, JC Craig, SD Navaneethan, M Tonelli, F Pellegrini, ... Annals of internal medicine 157 (4), 263-275, 2012 | 407 | 2012 |
| The number, quality, and coverage of randomized controlled trials in nephrology GFM Strippoli, JC Craig, FP Schena Journal of the American Society of Nephrology 15 (2), 411-419, 2004 | 374 | 2004 |
| Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease GFM Strippoli, C Bonifati, ME Craig, SD Navaneethan, JC Craig, ... Cochrane Database of Systematic Reviews 2010 (4), 1996 | 350 | 1996 |
| Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis J Lv, P Ehteshami, MJ Sarnak, H Tighiouart, M Jun, T Ninomiya, C Foote, ... Cmaj 185 (11), 949-957, 2013 | 335 | 2013 |
